Pfizer to operate 1st US plant producing Paxlovid ingredients

Biopharmaceutical company Pfizer will manufacture materials for the antiviral drug Paxlovid in Kalamazoo, Mich., after a $120 million investment for the treatment’s first stateside factory.

Advertisement

The nation’s most prescribed oral COVID-19 treatment — which reduced COVID-19 hospitalizations and deaths by 89 percent in a phase 2/3 study — has nearly 3 million orders with more than 1 million prescriptions filled, according to a June 1 HHS report. 

The deal “will allow Pfizer to increase supply by an additional 4 million packs of Paxlovid, allowing us to meet global demand and help increase overall access,” Pfizer spokesperson Julia Cohen told The Hill.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.